• The global Non-sterile Liquid market was valued at US$ 2675.3 million in 2023 and is projected to reach US$ 3954.6 million by 2030, at a CAGR of 5.7% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
• The global key manufacturers of Non-sterile Liquid include Nycomed, AbbVie, Aenova, APPCO, Atral Pharmaceutical, Aurigene Pharmaceutical Services, Biological E. Ltd., BioPlus Life Sciences and Bora Pharmaceuticals, etc. in 2023, the global top five players have a share approximately % in terms of revenue.
• Non-sterile liquid can be used to deliver a variety of medications, including prescription drugs, nonprescription drugs, vitamins, dietary supplements, and nutraceuticals.
• This report aims to provide a comprehensive presentation of the global market for Non-sterile Liquid, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-sterile Liquid. This report contains market size and forecasts of Non-sterile Liquid in global, including the following market information:
Email: help@24marketresearch.com
Call: 1(332) 2424 294 (Int'l)
